Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

Has over 150 years of combined biotech/pharma industry experience

Has been directly involved in over 35 Investigational New Drug applications (INDs)

Are responsible for 70 therapeutics currently in the clinic

Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate is a prize sponsor of the 2021 @ASCEPTanz Student Forum Symposium. Register or submit an abstract by 24 September via the links below.

BioCurate Chairman and Director the Hon John Brumby shares his thoughts on Australian biotech with @Informa_Oz ahead of his keynote address at #BioConnectionsAUS21. Read more: https://www.informa.com.au/insight/john-brumby/

The definition of "proof of concept" that is more commonly recognised in industry refers to the preliminary information gathered during the Phase I and Phase IIA stages of clinical trials. Read more what this entails via https://www.biocurate.com/resources/proof-of-concept-industrys-perspective/

BioCurate is proud to support @ACAN_Course. This intensive course for students teaches both advanced theory & hands-on-practice of latest neuroscience techniques. We're excited to support emerging Australian neuroscientists. More details http://bit.ly/3cyp3Fx @ausneurosoc